581 related articles for article (PubMed ID: 34825849)
1. Construction of a circRNA-miRNA-mRNA Regulated Pathway Involved in EGFR-TKI Lung Adenocarcinoma Resistance.
Dai C; Liu B; Li S; Hong Y; Si J; Xiong Y; Wu N; Ma Y
Technol Cancer Res Treat; 2021; 20():15330338211056809. PubMed ID: 34825849
[No Abstract] [Full Text] [Related]
2. Comprehensive Analysis of Circular RNA Expression Profiles in Gefitinib-Resistant Lung Adenocarcinoma Patients.
Zou J; Lan H; Li W; Xie S; Tong Z; Song X; Wang C
Technol Cancer Res Treat; 2022; 21():15330338221139167. PubMed ID: 36537128
[No Abstract] [Full Text] [Related]
3. A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop.
Wu DW; Wang YC; Wang L; Chen CY; Lee H
Theranostics; 2018; 8(5):1256-1269. PubMed ID: 29507618
[No Abstract] [Full Text] [Related]
4. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.
Gao L; Zhang L
BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211
[TBL] [Abstract][Full Text] [Related]
5. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.
Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ
J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071
[TBL] [Abstract][Full Text] [Related]
6. Hsa_circ_0005576 promotes osimertinib resistance through the miR-512-5p/IGF1R axis in lung adenocarcinoma cells.
Liu S; Jiang Z; Xiao P; Li X; Chen Y; Tang H; Chai Y; Liu Y; Zhu Z; Xie Q; He W; Ma Y; Jin L; Feng W
Cancer Sci; 2022 Jan; 113(1):79-90. PubMed ID: 34706132
[TBL] [Abstract][Full Text] [Related]
7. Construction of a circular RNA-microRNA-messenger RNA regulatory network of hsa_circ_0043256 in lung cancer by integrated analysis.
Li Y; Shi R; Zhu G; Chen C; Huang H; Gao M; Xu S; Cao P; Zhang Z; Wu D; Li X; Liu H; Chen J
Thorac Cancer; 2022 Jan; 13(1):61-75. PubMed ID: 34806315
[TBL] [Abstract][Full Text] [Related]
8. Construction of a circRNA-miRNA-mRNA network based on differentially co-expressed circular RNA in gastric cancer tissue and plasma by bioinformatics analysis.
Gong Y; Jiao Y; Qi X; Fu J; Qian J; Zhu J; Yang H; Tang L
World J Surg Oncol; 2022 Feb; 20(1):34. PubMed ID: 35164778
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA CRNDE Is Involved in Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutant Lung Cancer via eIF4A3/MUC1/EGFR Signaling.
Takahashi S; Noro R; Seike M; Zeng C; Matsumoto M; Yoshikawa A; Nakamichi S; Sugano T; Hirao M; Matsuda K; Hamada M; Gemma A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924522
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA hsa_circ_0000376 Participates in Tumorigenesis of Breast Cancer by Targeting miR-1285-3p.
Peng Z; Xu B; Jin F
Technol Cancer Res Treat; 2020; 19():1533033820928471. PubMed ID: 32462972
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma.
Kang DH; Jung SS; Yeo MK; Lee DH; Yoo G; Cho SY; Oh IJ; Kim JO; Park HS; Chung C; Lee JE
BMC Cancer; 2020 Jun; 20(1):571. PubMed ID: 32552717
[TBL] [Abstract][Full Text] [Related]
12. Construction of endogenous RNA regulatory network for colorectal cancer based on bioinformatics.
Li Y; Yuan F; Lin Z; Pan Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):416-430. PubMed ID: 35545337
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA (circ)_0129047 upregulates bone morphogenetic protein receptor type 2 expression to inhibit lung adenocarcinoma progression by sponging microRNA (miR)-1206.
Xue X; Chen Y
Bioengineered; 2022 May; 13(5):12067-12087. PubMed ID: 35570745
[TBL] [Abstract][Full Text] [Related]
14. Suppression of tumor immune microenvironment via microRNA-1 after epidermal growth factor receptor-tyrosine kinase inhibitor resistance acquirement in lung adenocarcinoma.
Kawana S; Saito R; Miki Y; Kimura Y; Abe J; Sato I; Endo M; Sugawara S; Sasano H
Cancer Med; 2021 Jan; 10(2):718-727. PubMed ID: 33305905
[TBL] [Abstract][Full Text] [Related]
15. hsa_circ_0000729, a potential prognostic biomarker in lung adenocarcinoma.
Li S; Sun X; Miao S; Lu T; Wang Y; Liu J; Jiao W
Thorac Cancer; 2018 Aug; 9(8):924-930. PubMed ID: 29932500
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA-microRNA-mRNA network identified circ_0007618 and circ_0029426 as new valuable biomarkers for lung adenocarcinoma.
Zhang Q; Sun Y; Wang C; Shao F
Bioengineered; 2022 Mar; 13(3):6258-6271. PubMed ID: 35212617
[TBL] [Abstract][Full Text] [Related]
17. Screening Circular RNAs Related to Acquired Gefitinib Resistance in Non-small Cell Lung Cancer Cell Lines.
Wen C; Xu G; He S; Huang Y; Shi J; Wu L; Zhou H
J Cancer; 2020; 11(13):3816-3826. PubMed ID: 32328186
[No Abstract] [Full Text] [Related]
18. Construct a circRNA/miRNA/mRNA regulatory network to explore potential pathogenesis and therapy options of clear cell renal cell carcinoma.
Bai S; Wu Y; Yan Y; Shao S; Zhang J; Liu J; Hui B; Liu R; Ma H; Zhang X; Ren J
Sci Rep; 2020 Aug; 10(1):13659. PubMed ID: 32788609
[TBL] [Abstract][Full Text] [Related]
19. A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma.
Han X; Liang L; He C; Ren Q; Su J; Cao L; Zheng J
BMC Complement Med Ther; 2023 Nov; 23(1):422. PubMed ID: 37990309
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics Analysis Predicts hsa_circ_0026337/miR-197-3p as a Potential Oncogenic ceRNA Network for Non-Small Cell Lung Cancers.
Zhang Q; Kang L; Li X; Li Z; Wen S; Fu X
Anticancer Agents Med Chem; 2022; 22(5):874-886. PubMed ID: 34254931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
